PIA
ANAC

Piedmont Investment Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Piedmont Investment Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-21
Closed -$2.47K – 440
2015
Q3 		$2.47K Sell
21
-17
-45% -$2.22K ﹤0.01% 310
2015
Q2 		$2.94K Buy
+38
New +$2.49K ﹤0.01% 299

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Piedmont Investment Advisors's ANAC Position: Q4 2015 in Review

Piedmont Investment Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 21 shares — an estimated $2.47K sold.

Piedmont Investment Advisors first reported a position in ANAC in Q2 2015 and held it in 2 quarters. The position peaked at $2.94K in Q2 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

  • Piedmont Investment Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
  • Piedmont Investment Advisors sold 21 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $2.47K.
  • Piedmont Investment Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 2 quarters.
  • Piedmont Investment Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $2.94K in Q2 2015.
  • 214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on Piedmont Investment Advisors's 13F filing for Q4 2015, filed 21 Jan 2016.